Company Number: 15219350

Analysis Date: 2025-07-29 12:49 UTC

1. Credit Opinion: DECLINE
   Atlas Infusion Ltd is a recently incorporated micro-entity with minimal financial history and very limited assets (£100 current assets, net current assets, and shareholders funds). The company’s financials do not show any revenue or profit data, and the balance sheet is effectively nominal. There is no evidence of operational scale or cash flow capacity to service debt or credit lines. The single director has full control but no disclosed financial strength or trading track record. Given the lack of financial substance, operating history, and absence of meaningful working capital, extending credit at this stage would carry high risk.

2. Financial Strength:
   The balance sheet is extremely thin with only £100 in current assets and net assets. No fixed assets or liabilities are reported. The company qualifies as a micro-entity and has filed under the small companies regime with exemption from audit. The shareholders’ funds equal current assets, indicating no debt or external financing. This minimal capital base provides no cushion against operational volatility or economic stress.

3. Cash Flow Assessment:
   No detailed profit and loss information is provided, and no cash flow statements are available. The nominal current assets of £100 suggest negligible liquidity and working capital. The company employs one person (likely the director). Without operating revenues or cash inflows, the company’s ability to generate positive cash flow to meet obligations is unproven.

4. Monitoring Points:

• Monitor filing of next sets of accounts for evidence of trading activity, revenue, and profit generation.
• Track changes in working capital and cash balances to assess liquidity trends.
• Review director’s credit history and any additional financial disclosures.
• Watch for any capital injections or third-party financing that could strengthen the balance sheet.